SCHEMBL29944879

SCHEMBL29944879

CCOC(=O)c1cc(N)cc(Br)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.60
CYP1A2 P05177 2/20 0.58
LMNA P02545 1/20 0.58
CYP3A4 P08684 1/20 0.58
MAOA P21397 1/20 0.58
CA12 O43570 3/20 0.55
CA1 P00915 3/20 0.55
CA2 P00918 3/20 0.55
CA7 P43166 3/20 0.55
CA9 Q16790 3/20 0.55
CA14 Q9ULX7 3/20 0.55
ESR1 P03372 2/20 0.46
ESR2 Q92731 1/20 0.46
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2725407 1.00 NPC1 (0.60) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL1278720 0.89 NPC1 (0.68) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL2810136 0.89 NPC1 (0.68) NPC1CYP1A2LMNACYP3A4MAOA
Hydrochloric Acid SCHEMBL9156219 0.87 NPC1 (0.66) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL10180584 0.87 CA12 (0.64) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL2712707 0.87 CA12 (0.64) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL584117 0.84 NPC1 (0.62) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL19386187 0.82 CA12 (0.55) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL330220 0.82 NPC1 (0.60) NPC1CYP1A2LMNACYP3A4MAOA
SCHEMBL29649183 0.82 NPC1 (0.60) NPC1CYP1A2LMNACYP3A4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed